Every day counts in the lives of patients with limited treatment options yet safe and effective medical innovations still fail to reach them for operational reasons. Biotech Square is tackling these risks by turning historical data into actionable insights.
We’re on a mission to improve clinical development outcomes, encourage more medical innovation and bring patients better options. We guide medical innovation down an optimal path for success with well-founded development plans, evidence-based study designs and robust execution strategies.
Founder & CEO
Amin brings 10 years of business development experience in the pharmaceutical and contract research industry. He has supported North American and European small to medium-sized companies access the US and Canadian markets, increase their revenues and establish strategic partnerships. He has negotiated and secured agreements with a number of Fortune 500 companies. While working with biopharmaceutical and medical device clinical development teams, Amin became passionate about addressing the delays and failures that make medical innovation unsustainable. He is a McGill University B.Sc. graduate in Biology and a Concordia University M.Sc. graduate in Cell & Molecular Biology.
Co-Founder & CTO